Answers are grounded in this paper and cite their sources.
Indirect evidence, mostly pharmacologic, has suggested a role for brain neurotransmitter amines such as norepinephrine in the production of depression or mania. Clinical investigations have supported this concept but also indicate that depression is probably a biochemically heterogeneous group of illnesses. There may be a clinically, biochemically, and pharmacologically definable subtype of depression in which there is a disorder of norepinephrine metabolism or disposition in brain. I review here the experimental data from which this hypothesis is derived.
No takes yet. Share an insight, caveat, or question.
James W. Maas (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: